BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Polfurmetinib readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Polfurmetinib\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05538130-2675@assetmemo.bio
DTSTAMP:20261121T010123Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:Polfurmetinib: Phase 1 readout est. (NCT05538130)
DESCRIPTION:Polfurmetinib\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A
  Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy
  or in Combination in People With Advanced Solid Tumors\nEstimated primary
  completion: 31 August 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/polfurmetinib#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT05538130
URL:https://assetmemo.bio/drug/polfurmetinib#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
